Science Explorer Back to mapMap
Discussion
Company · Bielefeld · Germany

axios Pharma (Germany)

axios-pharma.deROR OpenAlex
Research works
2
fractional, all time
Citations
42
17.4 per fractional work
Top-10% rate
1.7%
all institutions 10.0%
Open access
45%
world 40%
International
18%
world 18%
axios Pharma (Germany)

Not ranked overall: axios Pharma (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does axios Pharma (Germany) work in?

In all years, 50% of research at axios Pharma (Germany) is in Health Sciences, 29% in Life Sciences. Its largest fields are Medicine (50%), Biochemistry, Genetics and Molecular Biology (29%), Environmental Science (21%).

Health Sciences: 1 fractional works · 50.0% of its workMedicine: 1 fractional works · 50.0% of its workLife Sciences: 1 fractional works · 29.2% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 29.2% of its workPhysical Sciences: 0 fractional works · 20.8% of its workEnvironmental Science: 0 fractional works · 20.8% of its workALL ITS WORKaxios Pharma(Germany)2fractional works, all years
Life Sciences29%Physical Sciences21%Health Sciences50%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 3 fields, with their numbers
    1. Medicine150.0%
    1. Biochemistry, Genetics and Molecular Biology129.2%
    1. Environmental Science020.8%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Which research topics does axios Pharma (Germany) publish most on?

By volume: Bacteriophages and microbial interactions, RNA Interference and Gene Delivery, Obstructive Sleep Apnea Research and Cardiovascular and Diving-Related Complications.

Bacteriophages and micro…0Bacteriophages and microbial interactions: 0 fractional worksRNA Interference and Gen…0RNA Interference and Gene Delivery: 0 fractional worksObstructive Sleep Apnea …0Obstructive Sleep Apnea Research: 0 fractional worksCardiovascular and Divin…0Cardiovascular and Diving-Related Complications: 0 fractional worksBRCA gene mutations in cancer: 0 fractional worksCancer Genomics and Diagnostics: 0 fractional worksGlobal Cancer Incidence and Screening: 0 fractional works
EcologyMolecular BiologyPhysiologyPulmonary and Respiratory Medicine3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Bacteriophages and microbial interactions Ecology 0 works
  2. 2 RNA Interference and Gene Delivery Molecular Biology 0 works
  3. 3 Obstructive Sleep Apnea Research Physiology 0 works
  4. 4 Cardiovascular and Diving-Related Complications Pulmonary and Respiratory Medicine 0 works
  5. 5 BRCA gene mutations in cancer Genetics 0 works
  6. 6 Cancer Genomics and Diagnostics Cancer Research 0 works
  7. 7 Global Cancer Incidence and Screening Oncology 0 works
  8. 8 Pharmaceutical Economics and Policy Economics and Econometrics 0 works
  9. 9 Pharmaceutical Quality and Counterfeiting Public Health, Environmental and Occupational Health 0 works
  10. 10 Malaria Research and Control Public Health, Environmental and Occupational Health 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available45.0%not open55.0%

World: 40% of research is openly available.

with international co-authors17.5%domestic only82.5%

World: 18% is written across borders.

How has axios Pharma (Germany)'s research output changed?

20052010

Other research institutions in Bielefeld

All research institutions in Bielefeld

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about axios Pharma (Germany). Posts are plain text and can be reported.